Editor,—I read with interest the article by Turner et al, providing an update on carbon monoxide poisoning.¹ The authors correctly point out that hyperbaric therapy remains controversial, and that no controlled clinical trial had been conducted comparing hyperbaric oxygen (HBO) with normobaric oxygen (NBO). Since the date of acceptance of their paper a prospective, blinded, randomised trial comparing NBO with HBO has been published.² This …